PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Key immune substance linked to asthma, Stanford study finds

2011-07-02
(Press-News.org) STANFORD, Calif. — Stanford University School of Medicine investigators have linked a master molecule of the immune system, gamma-interferon, to the pathology of asthma, in a study of mice. This somewhat surprising finding — the key immune molecule has often been assumed to steer the immune system in a different direction from the cluster of allergic disorders to which asthma belongs — could lead to new treatments for the disease.

Gamma interferon's role in asthma has been fuzzy. High levels of this substance in children's blood seem to be protective against the development of asthma. Yet high gamma-interferon concentrations are often found in severe asthmatics' lungs. The new study, which will be published online July 1 in the Journal of Clinical Investigation, amasses several lines of evidence indicating that gamma-interferon may be contributing to the severity of asthma.

"People thought gamma-interferon might have something to do with driving asthma's pathology, but there wasn't a whole lot of corroborating evidence," said the study's senior author, Stephen Galli, MD, professor and chair of the Department of Pathology at Stanford medical school.

As many as 28 million people in the United States have asthma, whose prevalence has increased a great deal in the past few decades in developed countries. Asthma's signature symptom, extreme difficulty in breathing, is accompanied by transient narrowing and long-term inflammation of the air passages and, with time, lasting and detrimental structural changes in the architecture of the lungs.

Gamma-interferon, a signaling molecule secreted by certain immune cells, mobilizes the immune system to fight infectious pathogens — or, inappropriately, to attack healthy tissues, resulting in autoimmune disease. Asthma has been thought to result from a quite different mode of immune-system response that battles multi-celled parasites such as intestinal worms, but can unfortunately also trigger allergic reactions.

Another prominent feature of asthma is local abundance and activation, in lung tissue, of immune cells called mast cells, along with increased numbers of other kinds of inflammatory cells. But mast cells appear to be particularly critical in the development of asthma. These cells carry, on their surfaces, outward-facing antibodies that, in some cases, bind to allergens such as cat dander, pollen or cockroach droppings. This spurs the mast cells to secrete substances that trigger an asthma attack.

Curiously, mast cells have receptors for gamma-interferon.

The researchers used a mouse model of asthma to pin down gamma-interferon's role in that disease. Galli credits the study's first author, Mang Yu, MD, PhD, a senior research scientist who works closely with Galli, with producing the animal model of asthma that was used in the study. Five years ago, Yu, Galli and their associates had reported on Yu's then-new method for inducing asthma-like symptoms in ordinary, otherwise healthy mice in a study published in the same journal. The method involves repeatedly exposing the mice to a foreign substance over a period of 12 weeks.

In that 2006 study, the Stanford team employed both Yu's asthma-inducing protocol and mast-cell-lacking mice — pioneered by Galli, a specialist in mast-cell biology, in the 1980s — to show that, as good as Yu's protocol may be at producing asthma-like features in normal mice, it loses its ability to do so in mast-cell-free mice, even after those mice are supplied with mast cells that have been genetically altered so that all of their antibody-like surface receptors are defective. Providing those same mast-cell-lacking mice with healthy mast cells completely restored the protocol's capacity to induce asthma-like features.

In the new study, a similar approach — providing mast-cell-deficient mice with mast cells whose surface receptors for gamma interferon had been knocked out — showed a roughly equivalent ability to negate Yu's protocol's induction of asthma in the mice. Alternatively, giving fully functioning mast cells to such mice restored the protocol's power to trigger the asthma-associated symptoms and gene-activity level changes that normal mice develop under the regimen.

"This is potential important news, because it suggests that gamma-interferon might represent a therapeutic target," said Galli, who is also a professor of microbiology and immunology and the Mary Hewitt Loveless, MD Professor in the School of Medicine.

In addition to its discovery about gamma-interferon, the new study also further validated Yu's mouse model. Working with PhD student Alexander Morgan under the direction of his adviser, associate professor of pediatrics and of computer science Atul Butte, MD, PhD, the researchers were able to reproduce in such mice not only the gross symptoms of asthma but also the overall patterns of changes in the activity of genes in lung tissue that typify people with asthma.

Still, Galli said, "My MD doesn't stand for 'mouse doctor.' It stands for 'medical doctor.' And I recognize that human asthma is not necessarily the same as a mouse model of asthma, even a very good one like the one we're using. In implicating gamma-interferon as one of the drivers of pathology in this mouse model of asthma, we've raised just one question, which is: 'Could this also be true in humans and, if so, might interfering with gamma-interferon be helpful in treating them?' Mang and I can work on mice until the cows come home, and we couldn't answer that question."

Galli added a further caveat. "Even if levels of gamma-interferon are high in patients with severe asthma, that doesn't necessarily mean that if you block gamma-interferon they're going to get better. That would have to be established in clinical tests of human patients" — a prospect that may not be all that remote.

"The reason severe asthma exists is that some people don't respond well to typical therapies," said Sally Wenzel, MD, director of the University of Pittsburgh Asthma Institute and a professor of medicine at that university, who has identified increased levels of gamma-interferon in the lungs of severe asthma patients. Wenzel, who is familiar with Galli's new study but did not participate in it, said that she and Galli intend to collaborate in further research "to see whether the findings he's observed in the mouse model actually apply to living, breathing, asthmatic human beings."

### The Stanford study was funded entirely by the National Institutes of Health. Other co-authors were Michael Eckart, PhD, director of the Stanford Protein and Nucleic Acid Biotechnology Facility; and postdoctoral fellow Kaori Mukai, PhD, and senior research scientist Mindy Tsai, DMSc, both of the Galli lab.

For more information about Stanford medical school's Department Pathology, which sponsored this research, please visit http://pathology.stanford.edu/.

The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu. The medical school is part of Stanford Medicine, which includes Stanford Hospital & Clinics and Lucile Packard Children's Hospital. For information about all three, please visit http://stanfordmedicine.org/about/news.html.


ELSE PRESS RELEASES FROM THIS DATE:

Tom Bracken, President and CEO of NJ State Chamber, to Keynote Complimentary Breakfast Seminar July 19th

2011-07-02
Tom Bracken, the new President and CEO of the NJ State Chamber of Commerce, will keynote a breakfast seminar, "Five Common Mistakes That Could Cost You Millions!" that will be held at the Wilshire Grand Hotel in West Orange, New Jersey, on Tuesday, July 19th from 8 a.m. to 10 a.m. The seminar is designed to help owners, CFOs, CEOs and other key executives keep control of their business assets and make more money. Among the issues to be addressed are mergers and acquisitions, shareholder disputes and key operating agreements from the legal, accounting and insurance ...

Flapping micro air vehicles inspired by swifts

Flapping micro air vehicles inspired by swifts
2011-07-02
VIDEO: This shows the mechanism of the MAV and how it moves from three different views. Click here for more information. Scientists have designed a micro aircraft that will be able to flap, glide and hover like a bird. Researchers from the Biomimetics-Innovation-Centre in Germany have been inspired by birds to produce a new versatile design of Micro air vehicle (MAV) that combines flapping wings, which allow it to fly at slow speeds and hover, with the ability to glide, ...

Intertops Poker Hosting Daily WPT Paris Satellites with $12,500 Grand Prix de Paris Prize Packages to be Awarded

Intertops Poker Hosting Daily WPT Paris Satellites with $12,500 Grand Prix de Paris Prize Packages to be Awarded
2011-07-02
Daily satellites with a chance to ultimately win a $12,500 WPT Paris prize package begin Monday at Intertops Poker. There's also $10,000 up for grabs in the popular online poker room's weekly FPP points race which continues through July. It's going to be a very busy summer. With qualifiers throughout the day, every day, Intertops Poker players can satellite their way to a WPT Paris Super Satellite Final for as little as $0.20, or buy-in directly. Super Satellite Finals will be held on Sunday, July 31st and Sunday, August 28th. Tournament details: http://poker.intertops.com/en/promotions/#item_1486 Each ...

The loudest animal is recorded for the first time

2011-07-02
Scientists have shown for the first time that the loudest animal on earth, relative to its body size, is the tiny water boatman, Micronecta scholtzi. At 99.2 decibels, this represents the equivalent of listening to an orchestra play loudly while sitting in the front row. The frequency of the sound (around 10 kHz) is within human hearing range and Dr. James Windmill of the University of Strathclyde, explains one clue as to how loud the animals are: "Remarkably, even though 99% of sound is lost when transferring from water to air, the song is so loud that a person walking ...

Web weaving skills provide clues to aging

Web weaving skills provide clues to aging
2011-07-02
Young house spiders weave webs with perfect angles and regular patterns, but as they reach old age their webs deteriorate, showing gaping holes and erratic weaving. By using spiders as a simple model this research may provide insight into how age affects behaviour in other organisms, including humans. The reason web building skills are lost as spiders grow older may be due to degeneration of the central nervous system. PhD researcher, Mylène Anotaux, from Nancy University in France, says "Our next steps will be to understand whether age-induced changes in the central ...

Love2reward Unveils New Employee Benefits Portfolio

2011-07-02
The Employee Benefits offering from Love2reward includes: Flexebens Flexebens is a unique gift card platform which gives staff 7% discount every time they shop. The Flexebens card can be used in 23 leading retailers including River Island, Debenhams, New Look, Comet, Boots, Superdrug and Iceland, with new retailers joining the programme every month. Employees can save money onto their Flexebens card in one of two ways: Salary Exchange - this salary deduction scheme allows employees to choose how much money they wish to be taken from their salary each month. Each ...

Pre-pregnancy diet affects the health of future offspring

2011-07-02
Poor maternal diet before conception can result in offspring with reduced birth weights and increased risk of developing type II diabetes and obesity. This work, which is being presented at the Society for Experimental Biology Annual Conference in Glasgow on Saturday the 2nd of July, used an animal model to illustrate the importance of maternal diet even before pregnancy begins. During the study mice that were fed a low protein diet for ten weeks before conception (but had a normal diet during pregnancy) gave birth to offspring that had lower birth weights, showed catch-up ...

A VIP for normal brain development

2011-07-02
A team of researchers — led by Pierre Gressens, at Inserm U676, Paris, France, and Vincent Lelièvre, at CNRS UPR-3212, Strasbourg, France — has identified a signaling pathway key for normal brain development in the mouse. Of paramount importance, the data generated suggest that environmental factors, including maternal ones, can influence the final size of the brain. Individuals with microcephaly primary hereditary (MCPH) are born with a very small head and a small brain. They suffer mild developmental delay, hyperkinesia (excessive restlessness), and mild to severe cognitive ...

T-ing up a new target for Parkinson's disease treatment

2011-07-02
Parkinson disease (PD) affects 1-2% of the population over the age of 65 years. It results from loss or loss of function of nerve cells in the brain that coordinate movement. As a result, the hallmark symptoms of PD are trembling in hands, arms, legs, jaw, and face; stiffness of the limbs and trunk; slowness of movement; and impaired balance and coordination. There is no cure for PD, but symptoms can be alleviated with a variety of drugs. A team of researchers, led by Chung-Chin Kuo, at National Taiwan University College of Medicine, Taiwan, has now shown that pharmacological ...

Orthopedic Footwear Available to Address Any Needs

2011-07-02
Novis Shoes can provide shoe lifts custom designed for individual customers who experience leg length discrepancy problems. Our orthopedic footwear company specializes in all kinds of shoe modifications - from simple repairs to complete custom-made footwear - and can fill specific prescriptions quickly and easily. Our skilled Certified Pedorthist can apply shoe lifts for just about any shoe - for heights of 1/4 of an inch to six inches. Leg length discrepancy can be caused by a number of congenital and acquired conditions, including hip surgery, scoliosis, hip disease, ...

LAST 30 PRESS RELEASES:

Major review highlights latest evidence on real-time test for blood – clotting in childbirth emergencies

Inspired by bacteria’s defense strategies

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

University of Houston co-leads $25 million NIH-funded grant to study the delay of nearsightedness in children

NRG Oncology PREDICT-RT study completes patient accrual, tests individualized concurrent therapy and radiation for high-risk prostate cancer

Taking aim at nearsightedness in kids before it’s diagnosed

With no prior training, dogs can infer how similar types of toys work, even when they don’t look alike

Three deadliest risk factors of a common liver disease identified in new study

Dogs can extend word meanings to new objects based on function, not appearance

Palaeontology: South American amber deposit ‘abuzz’ with ancient insects

Oral microbes linked to increased risk of pancreatic cancer

Soccer heading does most damage to brain area critical for cognition

US faces rising death toll from wildfire smoke, study finds

Scenario projections of COVID-19 burden in the US, 2024-2025

Disparities by race and ethnicity in percutaneous coronary intervention

Glioblastoma cells “unstick” from their neighbors to become more deadly

Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer

New light on toxicity of Bluefin tuna

Menopause drug reduces hot flashes by more than 70%, international clinical trial finds

FGF21 muscle hormone associated with slow ALS progression and extended survival

Hitting the right note: The healing power of music therapy in the cardiac ICU

Cardiovascular disease risk rises in Mexico, despite improved cholesterol control

Flexible optical touch sensor simultaneously pinpoints pressure strength and location

Achalasia diagnosis simplified to AI plus X-ray

PolyU scholars pioneer smart and sustainable personal cooling technologies to address global extreme heat

NIH grant aims for childhood vaccine against HIV

Menstrual cycle and long COVID: A relation confirmed

WMO report on global water resources: 2024 was characterized by both extreme drought and intense rainfall

New findings explain how a mutation in a cancer-related gen causes pulmonary fibrosis

Thermal trigger

[Press-News.org] Key immune substance linked to asthma, Stanford study finds